Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Last Updated: January 22, 2020

DrugPatentWatch Database Preview


Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Women's Rogaine, and what generic alternatives are available?

Women's Rogaine is a drug marketed by Johnson And Johnson and is included in one NDA. There is one patent protecting this drug.

This drug has seventeen patent family members in eleven countries.

The generic ingredient in WOMEN'S ROGAINE is minoxidil. There are eight drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the minoxidil profile page.

US ANDA Litigation and Generic Entry Outlook for Women's Rogaine

  Start Trial

A generic version of WOMEN'S ROGAINE was approved as minoxidil by WATSON LABS on January 22nd, 2020.

International Patents:17
US Patents:1
Suppliers / Packagers: 1
Clinical Trials: 3
Formulation / Manufacturing:see details
DailyMed Link:WOMEN'S ROGAINE at DailyMed
Drug patent expirations by year for WOMEN'S ROGAINE
Recent Clinical Trials for WOMEN'S ROGAINE

Identify potential brand extensions & 505(b)(2) entrants

University of Minnesota - Clinical and Translational Science InstitutePhase 2
Wake Forest University Health SciencesPhase 4
The Skin of Color SocietyPhase 4

See all WOMEN'S ROGAINE clinical trials

Paragraph IV (Patent) Challenges for WOMEN'S ROGAINE
Tradename Dosage Ingredient NDA Submissiondate
MEN'S ROGAINE AEROSOL, FOAM;TOPICAL minoxidil 021812 2009-04-06
WOMEN'S ROGAINE AEROSOL, FOAM;TOPICAL minoxidil 021812 2009-04-06

US Patents and Regulatory Information for WOMEN'S ROGAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson WOMEN'S ROGAINE minoxidil AEROSOL, FOAM;TOPICAL 021812-002 Feb 28, 2014 OTC Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.